Clinical Trial Update: A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating HU6 vs placebo in adults with metabolic dysfunction-associated steatohepatitis (MASH); recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• HU6

Snippet

Sponsor: Rivus Pharmaceuticals, Inc. | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis | Phase 2 | Status: RECRUITING